Fishman Jay A LTD Tyra Biosciences, Inc. Transaction History

Fishman Jay A LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	SELL	$14.45 - $20.22 $564,995 - $790,602	-39,100 Reduced 75.78%	12,500 $199,000
Q2 2024 Jul 31, 2024	BUY	$14.45 - $20.22 $528,870 - $740,052	36,600 Added 244.0%	51,600 $825,000
Q1 2024 Apr 23, 2024	BUY	$11.61 - $20.0 $174,150 - $300,000	15,000 New	15,000 $245,000
Q2 2023 Aug 15, 2023	BUY	$11.99 - $17.51 $263,780 - $385,220	22,000 New	22,000 $374,000
Q4 2022 Feb 13, 2023	BUY	$5.68 - $8.81 $65,320 - $101,315	11,500 Added 109.52%	22,000 $167,000
Q3 2022 Oct 26, 2022	BUY	$6.61 - $12.42 $69,405 - $130,410	10,500 New	10,500 $92,000

112

43.1M

3.8K

Ticker TYRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,973,600
Market Cap $426M
Description
Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...

Get notified when there are updates to the investment portfolio of Fishman Jay A LTD, based on Form 13F filings with the SEC.

Stay updated on Fishman Jay A LTD with notifications on news.